Dengue - the underestimated risk in travellers.
暂无分享,去创建一个
[1] D. Gubler,et al. A dengue outbreak among camp participants in a Caribbean island, 1995. , 2007, Journal of travel medicine.
[2] S. Lawn,et al. Dengue hemorrhagic fever with fulminant hepatic failure in an immigrant returning to Bangladesh. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] T. John. Dengue fever and dengue haemorrhagic fever , 2003, The Lancet.
[4] S. McLellan,et al. Evaluation of fever in the returned traveler. , 2002, Primary care.
[5] N. Mühlberger,et al. Epidemiology and clinical features of imported dengue fever in Europe: sentinel surveillance data from TropNetEurop. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] C. Haritoglou,et al. A tourist with dengue fever and visual loss , 2002, The Lancet.
[7] W. Preiser,et al. Travel-Acquired Dengue Infection: Clinical Spectrum and Diagnostic Aspects , 2002, Infection.
[8] D. Vaughn,et al. Dengue: an escalating problem , 2002, BMJ : British Medical Journal.
[9] U. Thisyakorn,et al. Dengue infection: a global concern. , 2002, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[10] F. Cobelens,et al. Incidence and risk factors of probable dengue virus infection among Dutch travellers to Asia , 2002, Tropical medicine & international health : TM & IH.
[11] J. Lang,et al. Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses. , 2002, The American journal of tropical medicine and hygiene.
[12] N. Phuong,et al. Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever. , 2001, The American journal of tropical medicine and hygiene.
[13] N. White,et al. Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? , 2001, The Journal of infectious diseases.
[14] S. Halstead,et al. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. , 2001, The American journal of tropical medicine and hygiene.
[15] D. Vaughn,et al. Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers. , 2001, Vaccine.
[16] E. Schwartz,et al. Changing Epidemiology of Dengue Fever in Travelers to Thailand , 2000, European Journal of Clinical Microbiology and Infectious Diseases.
[17] E. Mendelson,et al. Evaluation of ELISA-based sero-diagnosis of dengue fever in travelers. , 2000, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[18] T. Jelínek,et al. Dengue fever in international travelers. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] S. Wahid,et al. A comparison of the pattern of liver involvement in dengue hemorrhagic fever with classic dengue fever. , 2000, The Southeast Asian journal of tropical medicine and public health.
[20] N. Bhamarapravati,et al. Live attenuated tetravalent dengue vaccine. , 2000, Vaccine.
[21] C. Sirivichayakul,et al. Dengue infection with unusual manifestations: a case report. , 2000, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[22] I. Srugo,et al. Dengue seroconversion among Israeli travelers to tropical countries. , 1999, Emerging infectious diseases.
[23] E. Chungue,et al. Dengue: an evaluation of dengue severity in French Polynesia based on an analysis of 403 laboratory‐confirmed cases , 1999, Tropical medicine & international health : TM & IH.
[24] N. White. Variation in virulence of dengue virus , 1999, The Lancet.
[25] S. Halstead,et al. Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever , 1999, The Lancet.
[26] R. Rico-Hesse,et al. Dengue Virus Structural Differences That Correlate with Pathogenesis , 1999, Journal of Virology.
[27] F. Pinheiro,et al. Re-emergence of dengue and emergence of dengue haemorrhagic fever in the Americas , 1997 .
[28] T. Jelínek,et al. Prevalence of infection with dengue virus among international travelers. , 1997, Archives of internal medicine.
[29] A. Nisalak,et al. Early clinical and laboratory indicators of acute dengue illness. , 1997, The Journal of infectious diseases.
[30] A. Nisalak,et al. Dengue in the early febrile phase: viremia and antibody responses. , 1997, The Journal of infectious diseases.
[31] M. Aye,et al. Risk factors in dengue shock syndrome. , 1997, The American journal of tropical medicine and hygiene.
[32] E. Mendelson,et al. Dengue fever among travelers. , 1996, The American journal of medicine.
[33] R. López-Vélez,et al. Dengue in Spanish travelers returning from the tropics , 1996, European Journal of Clinical Microbiology and Infectious Diseases.
[34] C. Chansang,et al. Dengue vector mosquitos at a tourist attraction, Ko Samui, in 1995. , 1996, The Southeast Asian journal of tropical medicine and public health.
[35] P. Vernazza,et al. [Imported dengue fever in Switzerland--serological evidence for a hitherto unexpectedly high prevalence]. , 1995, Swiss medical weekly.
[36] S. Lam,et al. Dengue haemorrhagic fever , 1995 .
[37] T. Monath,et al. Dengue: the risk to developed and developing countries. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[38] Y. Liaw,et al. Liver biochemical tests and dengue fever. , 1992, The American journal of tropical medicine and hygiene.
[39] M. Guzmán,et al. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. , 1990, The American journal of tropical medicine and hygiene.
[40] R. Rico-Hesse,et al. Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. , 1990, Virology.
[41] A. Nisalak,et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. , 1989, The American journal of tropical medicine and hygiene.
[42] A. Nisalak,et al. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. , 1989, The American journal of tropical medicine and hygiene.
[43] A. Nisalak,et al. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. , 1988, The American journal of tropical medicine and hygiene.
[44] S. Halstead,et al. Pathogenesis of dengue: challenges to molecular biology. , 1988, Science.
[45] S. Nimmannitya. Dengue haemorrhagic fever in Thailand. , 1987, The Southeast Asian journal of tropical medicine and public health.
[46] S. Nimmannitya,et al. Dengue haemorrhagic fever with unusual manifestations. , 1987, The Southeast Asian journal of tropical medicine and public health.
[47] D. Gubler,et al. Dengue shock syndrome in an American traveler with primary dengue 3 infection. , 1987, The American journal of tropical medicine and hygiene.
[48] S. Halstead,et al. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. , 1984, American journal of epidemiology.
[49] D. Gubler,et al. Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. , 1978, The American journal of tropical medicine and hygiene.
[50] L. Rosen,et al. Fatal hemorrhagic disease and shock associated with primary dengue infection on a Pacific island. , 1974, The American journal of tropical medicine and hygiene.
[51] M. Saeed,et al. Dengue and Dengue Hemorrhagic Fever , 2015 .
[52] B. Niklasson,et al. Dengue fever among Swedish tourists. , 1993, Scandinavian journal of infectious diseases.
[53] P. Thongcharoen. Monograph on dengue/dengue haemorrhagic fever , 1993 .
[54] A. Nisalak,et al. A prospective study of dengue infections in Bangkok. , 1988, The American journal of tropical medicine and hygiene.